Intocell Company
Intocell is a biotechnology company that develops antibody drug conjugate (ADC) platform technologies.
Employee Number:
11-50
Funding Status:
Early Stage Venture
Headquarters:
Daejeon, Taejon-jikhalsi, South Korea
Technology:
Immunotherapy
Estimated Revenue:
$1M to $10M
Founded Date:
2015
Industry:
PharmTech